Himisha Beltran
Harvard University
H-index: 72
North America-United States
Top articles of Himisha Beltran
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
G-protein signaling of oxytocin receptor as a potential target for cabazitaxel-resistant prostate cancer | PNAS nexus | Hiroshi Hongo Takeo Kosaka Ken-Ichi Takayama Yuto Baba Yota Yasumizu | 2024/1 |
Canonical Wnt signaling pathway (WSP) alterations in metastatic prostate cancer. | Sharon Choi Elizabeth Pan Andrew Elliott Himisha Beltran Justine Panian | 2024/2/1 | |
Noninvasive Detection of Neuroendocrine Prostate Cancer through Targeted Cell-free DNA Methylation | Cancer discovery | Gian Marco Franceschini Orsetta Quaini Kei Mizuno Francesco Orlando Yari Ciani | 2024/3/1 |
Molecular features of prostate cancer after neoadjuvant therapy in the phase 3 CALGB 90203 trial | JNCI: Journal of the National Cancer Institute | Takayuki Sumiyoshi Xiaofei Wang Evan W Warner Andrea Sboner Matti Annala | 2024/1/1 |
Interim results from a phase 1/2 study of HPN328, a tri-specific, half-life (T1/2) extended DLL3-targeting T-cell engager, in patients (pts) with neuroendocrine prostate cancer … | Himisha Beltran Afshin Dowlati Prantesh Jain Melissa Lynne Johnson Rachel E Sanborn | 2024/2/1 | |
Prognostic and predictive analyses of circulating plasma biomarkers in men with metastatic castration resistant prostate cancer treated with docetaxel/prednisone with or … | Prostate Cancer and Prostatic Diseases | Andrew B Nixon Yingmiao Liu Qian Yang Bin Luo Mark D Starr | 2024/2/12 |
A phase Ib trial of enzalutamide with oral decitabine/cedazuridine in metastatic castration-resistant prostate cancer (CRPC). | Arya Mariam Roy Dharmesh Gopalakrishnan Karan Jatwani Kelly Green Bailey Farmer | 2024/2/1 | |
Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes | Varadha Balaji Venkadakrishnan Adam G Presser Richa Singh Matthew A Booker Nicole A Traphagen | 2024/2/8 | |
Expert perspectives on controversies in castration-sensitive prostate cancer management: narrative review and report of the first US prostate cancer conference part 1 | E David Crawford Alan H Bryce Maha H Hussain Neeraj Agarwal Himisha Beltran | 2024/4/1 | |
Large Cell Neuroendocrine Prostate Cancer: Large Is Not Small | The Oncologist | Anthony V Serritella Himisha Beltran Tamara L Lotan David J VanderWeele Fatima Karzai | 2024/1/11 |
MYBL2 drives prostate cancer plasticity and identifies CDK2 as a therapeutic vulnerability in RB1-loss and neuroendocrine prostate cancer | bioRxiv | Beatriz German Jagpreet N Singh Marcos AdS Fonseca Deborah L Burkhart Anjali Sheahan | 2024/2/2 |
Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2 | Alan H Bryce E David Crawford Neeraj Agarwal Maha H Hussain Himisha Beltran | 2024/4/1 | |
Androgen receptor-negative prostate cancer is vulnerable to SWI/SNF-targeting degrader molecules | bioRxiv | Phillip D Thienger Philip D Rubin Xiaosai Yao Andrej Benjak Sagar Shah | 2024 |
Lurbinectedin in prostatic small cell and neuroendocrine carcinoma. | Haley M Meyer Rajitha Sunkara Himisha Beltran Emily Rothmann Kevin Dale Courtney | 2024/2/1 | |
569 Investigating the Role of FOXA2 During the Transition to Neuroendocrine Prostate Cancer | Journal of Clinical and Translational Science | Richard Garner Nicholas Brady Kate Dunmore Richa Singh Alyssa Bagadion | 2024/4 |
Author Correction: Evolution of structural rearrangements in prostate cancer intracranial metastases | NPJ Precision Oncology | Francesca Khani William F Hooper Xiaofei Wang Timothy R Chu Minita Shah | 2023/11/2 |
Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer | Nature cancer | Martin K Bakht Yasutaka Yamada Sheng-Yu Ku Varadha Balaji Venkadakrishnan Joshua A Korsen | 2023/5 |
Abstract IA016: Epigenetic crosstalk associated with prostate cancer lineage plasticity | Cancer Research | David Rickman Richa Singh Varadha Balaji Venkadakrishnan Yasutaka Yamada Himisha Beltran | 2023/6/2 |
Chemokine receptor CXCR7 activates Aurora Kinase A and promotes neuroendocrine prostate cancer growth | The Journal of Clinical Investigation | Galina Gritsina Ka-wing Fong Xiaodong Lu Zhuoyuan Lin Wanqing Xie | 2023/8/1 |
Fragmentomic analysis of circulating tumor DNA-targeted cancer panels | Annals of Oncology | KT Helzer MN Sharifi JM Sperger Y Shi M Annala | 2023/9/1 |
